中国大陆1-29岁人群乙型肝炎病毒基因型流行病学分布
基于2014年全国乙型肝炎血清学调查中517例1-29岁HBsAg阳性者,对369例成功测序样本分析HBV基因型分布。结果显示基因型B占45.0%、C占36.6%,B2和C2为主要亚型,基因型分布存在地区与民族差异,但与性别、年龄组及乙肝疫苗接种史无统计学差异。
要点
- 1-29岁HBsAg阳性者中HBV基因型以B(45.0%)和C(36.6%)为主。
- B2(43.9%)与C2(25.2%)为主要亚基因型。
- 基因型分布存在地区与民族差异,与性别、年龄、疫苗接种史无关。
核心结论
- 在预防措施使HBV流行率显著下降后,中国大陆1-29岁人群HBV基因型B流行率高于C,B2和C2为地方性流行亚型。
- 乙肝疫苗接种或其他因素未干扰HBV基因型分布,HBV基因型监测对应对未来预防政策潜在变化和影响至关重要。
研究设计与样本
- 纳入2014年全国HBV血清学调查中517例1-29岁HBsAg阳性者,最终369例(71.4%)纳入分析。
- 通过PCR扩增和测序获得HBV全基因组,用系统发育分析确定基因型,并结合问卷信息分析基因型分布。
主要发现
- 369例中HBV基因型为B(45.0%)、C(36.6%)、D(6.0%)、C/D(9.8%)、B/C(2.2%)和I(0.5%)。
- 七个地区间HBV基因型地理差异显著。
- 发现三种血清型:adw(47.2%)、adr(35.5%)和ayw(17.3%)。
- 主要亚基因型为B2(43.9%)和C2(25.2%)。
- 汉族与其他民族的优势基因型不同;按性别、年龄组或乙肝疫苗接种史比较,基因型分布无统计学差异。
临床怎么用
- 在1-29岁人群中监测HBV基因型分布,关注B2和C2亚型及地区与民族差异。
- 评估乙肝疫苗接种史时无需因基因型分布差异而调整预防策略,但应持续监测基因型变化。
局限性
- 仅369例(71.4%)HBsAg阳性者成功纳入基因型分析,可能存在选择偏倚。
- 研究基于2014年全国血清学调查,未报告更近期基因型分布数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To analyze the epidemiological distribution of Hepatitis B virus (HBV) genotype in the mainland of China following the implementation of effective preventive measures. METHODS: Five hundred and seventeen HBsAg-positive subjects aged 1-29 years surveyed in the 2014 national HBV sero-survey in the mainland of China were enrolled in the study. The full-length HBV genome was obtained by PCR amplification and sequencing. The HBV genotype was determined by phylogenetic analysis. Combined with questionnaire information, HBV genotype distribution was analyzed. RESULTS: Of the 517 HBsAg-positive subjects, 369 (71.4%) were included in the analysis. HBV genotypes found were B (45.0%), C (36.6%), D (6.0%), C/D (9.8%), B/C (2.2%), and I (0.5%). Geographic differences in HBV genotype were significant for seven regions. Three serotypes were found: adw (47.2%), adr (35.5%), and ayw (17.3%). B2 (43.9%) and C2 (25.2%) were the two major subgenotypes. The predominant genotypes differed between the Han group and the other ethnic groups. No statistical differences in genotype distribution were found by gender, age group, or hepatitis B (HepB) vaccination history. CONCLUSION: The prevalence of HBV genotype B was higher than that of genotype C with subgenotypes B2 and C2 endemic in 1-29-year-olds in the mainland of China, after HBV prevalence has reduced significantly due to the implementation of preventive measures. HepB vaccination or other factors did not interfere with HBV genotype distribution. The surveillance of HBV genotype was essential for responding to the potential changes and impact on the preventive policies in the future.
引用
- Su QD, Zhang S, Wang F, et al. Epidemiological distribution of hepatitis B virus genotypes in 1-29-year-olds in the mainland of China. Vaccine. 2020. PMID: 33187763. doi:10.1016/j.vaccine.2020.09.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。